{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:18:18Z","timestamp":1771852698819,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jccjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jcrc.2016.06.026","type":"journal-article","created":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T05:31:35Z","timestamp":1468128695000},"page":"259-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Comparison of 1,3-\u03b2- d -glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients"],"prefix":"10.1016","volume":"36","author":[{"given":"Tobias","family":"Lahmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Neuenhahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Held","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Rasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcrc.2016.06.026_bb0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jcrc.2016.06.026_bb0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cid\/civ293","article-title":"Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)","volume":"61","author":"Cornely","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","article-title":"Laboratory diagnosis of invasive aspergillosis","volume":"5","author":"Hope","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jcrc.2016.06.026_bb0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0030","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","article-title":"ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients","volume":"47","author":"Marchetti","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcrc.2016.06.026_bb0035","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/JCM.37.10.3223-3228.1999","article-title":"Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis","volume":"37","author":"Maertens","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0045","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"4","author":"Leeflang","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.jcrc.2016.06.026_bb0055","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/528714","article-title":"Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications","volume":"46","author":"Miceli","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/CDLI.10.5.882-885.2003","article-title":"Serum glucan levels are not specific for presence of fungal infections in Intensive Care Unit patients","volume":"10","author":"Digby","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0065","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u2192 3)-\u03b2-D-glucan assay as an aid to diagnosis of fungal Infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0070","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","article-title":"Diagnostic performance of the (1-3)--D-glucan assay for invasive fungal disease","volume":"49","author":"Koo","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jcrc.2016.06.026_bb0075","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jcrc.2016.06.026_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.jcrc.2016.06.026_bb0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0090","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"Beta-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0095","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","article-title":"Beta-D-Glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study","volume":"49","author":"De Vlieger","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jcrc.2016.06.026_bb0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","article-title":"A systematic review and metaanalysis of diagnostic accuracy of serum 1, 3-\u03b2-d-glucan for invasive fungal infection: focus on cutoff levels","volume":"48","author":"He","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"1\u20132","key":"10.1016\/j.jcrc.2016.06.026_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1439-0507.1996.tb00078.x","article-title":"Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis","volume":"39","author":"Kappe","year":"1996","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.jcrc.2016.06.026_bb0115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422009","article-title":"Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance","volume":"190","author":"Marr","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jcrc.2016.06.026_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JCM.00506-08","article-title":"Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients","volume":"47","author":"Hachem","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.jcrc.2016.06.026_bb0125","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"52","author":"Hoenigl","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.jcrc.2016.06.026_bb0130","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","volume":"42","author":"Kawazu","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"8941","key":"10.1016\/j.jcrc.2016.06.026_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(95)91152-9","article-title":"Plasma (1\u2013>3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes","volume":"345","author":"Obayashi","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1620\/tjem.217.117","article-title":"Measurement of (1-3)-Beta-D-glucan derived from different gauze types","volume":"217","author":"Kanamori","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0145","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1755.2001.00802.x","article-title":"Influence of various hemodialysis membranes on the plasma (1\u00a13)-D-glucan level","volume":"60","author":"Kanda","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0150","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/AAC.00658-06","article-title":"Reactivity of (1\u00a13)-Beta-D-glucan assay with commonly used intravenous antimicrobials","volume":"50","author":"Marty","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s100470300008","article-title":"Experimental proof of contamination of blood components by (1,3)-Beta-D-glucan caused by filtration with cellulose filters in the manufacturing process","volume":"6","author":"Nagasawa","year":"2003","journal-title":"J Artif Organs"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0160","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/JCM.03567-13","article-title":"Use and limits of (1 \u2192 3)-\u03b2-d-glucan assay (fungitell), compared to galactomannan determination (platelia Aspergillus), for diagnosis of invasive Aspergillosis","volume":"52","author":"Sulahian","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0165","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JCM.02091-07","article-title":"Contribution of the (1 \u2192 3)-\u03b2-d-glucan assay for diagnosis of invasive fungal infections","volume":"46","author":"Persat","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.jcrc.2016.06.026_bb0170","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1086\/588295","article-title":"Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.","volume":"46","author":"Obayashi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2016.06.026_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1755.2001.00802.x","article-title":"Influence of various hemodialy-sis membranes on the plasma (1,3)-beta-D-glucan level","volume":"60","author":"Kanda","year":"2001","journal-title":"Kidney Int"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394411630168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394411630168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T18:49:45Z","timestamp":1600886985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394411630168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":35,"alternative-id":["S088394411630168X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2016.06.026","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of 1,3-\u03b2-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2016.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}